Epidemiology Of Uterine Fibroid Disease In Lebanon: A Case-Control Study
DOI:
https://doi.org/10.38179/ijcr.v3i1.113Keywords:
Uterine leiomyoma, Pelvic tumors, Risk factors, Lebanon, Epidemiology, Health related quality of lifeAbstract
Background: Uterine leiomyoma (UL) are women’s most common pelvic tumors, benign in nature, growing during reproductive age, and presenting with abnormal uterine bleeding or pelvic pain and pressure. Many risk factors may contribute to UL, such as family history, obesity, and early menarche. Despite the fact that UL symptoms may improve using many medical or surgical treatments, the health-related quality of life (HRQoL) is considerably affected by their presence. Based on all of the above, we conducted this study which is to the best of our knowledge, the first of its kind in Lebanon aiming to assess the risk factors of UL among the Lebanese population and provide an overview of the diagnostic methods, treatment modalities, and HRQoL among patients.
Subjects & Methods: This is an epidemiologic case-control retrospective study, of 668 women of reproductive age, of different nationalities living in Lebanon, divided into 167 cases and 501 controls, conducted between January 2016 and February 2018, in Beirut, Lebanon, in Rafic Hariri University Hospital (RHUH) and Makassed General Hospital (MGH), using charts, questionnaires, and telephone calls. The statistical program Statistical Package for the Social Sciences 19 (SPSS-19) was used for data analysis. A multivariate analysis was also done. Two-sided data analysis was employed and statistical significance was considered for a p-value of ≤ 0.05.
Results: Risk factors of UL were older age (>40), early menarche, family history, oral contraceptives (OCP) use, high body mass index (BMI) (>29), and chronic diseases. Smoking and sports were protective factors. The highest effectiveness in diagnosis was attributable to pelvic ultrasonography (94.8% of cases), magnetic resonance imaging (MRI) (85.2% of cases), and hysteroscopy (77.8% of cases). Hysterectomy was the most used treatment method (83.8% of cases), followed by hysteroscopy (77.8%) and uterine artery embolization (UAE) (72.7%). Women with leiomyoma reported that their HRQoL is negatively affected by this condition.
Conclusion: This study showed many risk factors for UL, and the statistical significance of techniques for their diagnosis and treatment, in order to prevent their complications and decrease their impact on HRQoL.
References
Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501-1512. PMID: 28296146. https://doi.org/10.1111/1471-0528.14640
Williams ARW. Uterine fibroids - what's new?. F1000Res. 2017;6:2109. PMID: 29259779. https://doi.org/10.12688/f1000research.12172.1
Moravek MB, Bulun SE. Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution. Curr Opin Obstet Gynecol. 2015;27(4):276-283. PMID: 26107781. https://doi.org/10.1097%2FGCO.0000000000000185
Ciavattini A, Di Giuseppe J, Stortoni P, et al. Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet Gynecol Int. 2013;2013:173184. PMID: 24163697. https://doi.org/10.1155/2013/173184
Laughlin-Tommaso SK, Hesley GK, Hopkins MR, Brandt KR, Zhu Y, Stewart EA. Clinical limitations of the International Federation of Gynecology and Obstetrics (FIGO) classification of uterine fibroids. Int J Gynaecol Obstet. 2017;139(2):143-148. PMID: 28715088. https://doi.org/10.1002/ijgo.12266
Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100-107. PMID: 12548202. https://doi.org/10.1067/mob.2003.99
Ilaria Soave, Marci R. From obesity to uterine fibroids: an intricate network. Curr Med Res Opin. 2018;34(11):1877-1879. PMID: 30049230. https://doi.org/10.1080/03007995.2018.1505606
Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007;87(4):725-736. PMID: 17430732. https://doi.org/10.1016/j.fertnstert.2007.01.093
Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2018;46:3-11. PMID: 29054502. https://doi.org/10.1016/j.bpobgyn.2017.09.004
Manjiri R, Podder, Rahul Podder, Poonam V. Shivkumar. Demographic parameters of women with uterine fibroids presenting as abnormal uterine bleeding. IJRCOG. 2018. https://dx.doi.org/10.18203/2320-1770.ijrcog20182906
Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007;87(4):725-736. PMID: 17430732. https://doi.org/10.1016/j.fertnstert.2007.01.093
Sparic R, Mirkovic L, Malvasi A, Tinelli A. Epidemiology of Uterine Myomas: A Review. Int J Fertil Steril. 2016;9(4):424-435. PMID: 26985330. https://doi.org/10.22074%2Fijfs.2015.4599
Tadir Y, Glezerman M, Goldchmit C. Uterine fibroids. Harefuah. 2008.
Wise LA, Laughlin-Tommaso SK. Epidemiology of Uterine Fibroids: From Menarche to Menopause. Clin Obstet Gynecol. 2016;59(1):2-24. PMID: 26744813. https://doi.org/10.1097/grf.0000000000000164
Olufowobi O, Sharif K, Papaionnou S, Neelakantan D, Mohammed H, Afnan M. Are the anticipated benefits of myomectomy achieved in women of reproductive age? A 5-year review of the results at a UK tertiary hospital. Journal of Obstetrics and Gynaecology. 2004;24(4).
Oindi, F. J. , & Mwaniki, M. A. Uterine Fibroids: Clinical Presentation. Leiomyoma. IntechOpen. 2019. https://doi.org/10.5772/intechopen.88473
Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril. 2009;91(4):1215-1223. PMID: 18339376. https://doi.org/10.1016/j.fertnstert.2008.01.051
Brosens J, Campo R, Gordts S, Brosens I. Submucous and outer myometrium leiomyomas are two distinct clinical entities. Fertil Steril. 2003;79(6):1452-1454. PMID: 12798900. https://doi.org/10.1016/s0015-0282(03)00346-7
De La Cruz MS, Buchanan EM. Uterine Fibroids: Diagnosis and Treatment. Am Fam Physician. 2017;95(2):100-107. PMID: 28084714.
Khan AT, Shehmar M, Gupta JK. Uterine fibroids: current perspectives. Int J Womens Health. 2014;6:95-114. PMID: 24511243. https://doi.org/10.2147/ijwh.s51083
Mas A, Tarazona M, Dasí Carrasco J, Estaca G, Cristóbal I, Monleón J. Updated approaches for management of uterine fibroids. Int J Womens Health. 2017;9:607-617. PMID: 28919823. https://doi.org/10.2147%2FIJWH.S138982
Homer H, Saridogan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril. 2010;94(1):324-330. PMID: 19361799. https://doi.org/10.1016/j.fertnstert.2009.02.069
Stokes LS, Wallace MJ, Godwin RB, Kundu S, Cardella JF; Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomas. J Vasc Interv Radiol. 2010;21(8):1153-1163. PMID: 20558083. https://doi.org/10.1016/j.jvir.2010.03.015
Puri K, Famuyide AO, Erwin PJ, Stewart EA, Laughlin-Tommaso SK. Submucosal fibroids and the relation to heavy menstrual bleeding and anemia. Am J Obstet Gynecol. 2014;210(1):38.e1-38.e387. PMID: 24080304. https://doi.org/10.1016/j.ajog.2013.09.038
Huang HK, Kor CT, Chen CP, et al. Increased Risk of Venous Thromboembolism in Women with Uterine Leiomyoma: A Nationwide, Population-Based Case-Control Study. Acta Cardiol Sin. 2018;34(1):66-76. PMID: 29375226. https://doi.org/10.6515%2FACS.201801_34(1).20170901B
Parker-Autry C, Harvie H, Arya LA, Northington GM. Lower urinary tract symptoms in patients with uterine fibroids: association with fibroid location and uterine volume. Female Pelvic Med Reconstr Surg. 2011;17(2):91-96. PMID: 22453695. https://doi.org/10.1097/spv.0b013e31820c99a9
Soliman AM, Margolis MK, Castelli-Haley J, et al. Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey, Curr Med Res Opin. 2017;33(11):1971-1978. https://doi.org/10.1080/03007995.2017.1372107
Hervé F, Katty A, Isabelle Q, Céline S. Impact of uterine fibroids on quality of life: a national cross-sectional survey. Eur J Obstet Gynecol Reprod Biol. 2018;229:32-37. PMID: 30099225. https://doi.org/10.1016/j.ejogrb.2018.07.032
Fuldeore MJ, Soliman AM. Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis. Int J Womens Health. 2017;9:403-411. PMID: 28652819. https://doi.org/10.2147%2FIJWH.S133212
Sarkodie, B.D., Botwe, B.O., Adjei, D.N. et al. Factors associated with uterine fibroid in Ghanaian women undergoing pelvic scans with suspected uterine fibroid. Fertil Res and Pract. 2016. https://doi.org/10.1186/s40738-016-0022-9
Abayomi A, Afolabi BM, Ajayi V, et al. Sizes, Numbers and Distribution of Uterine Fibroids Enucleated At Laparoscopic Myomectomy from Nigerian Women with Primary or Secondary Infertility. Gynecol Reprod Health. 2017;1(1):1-8.
Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health. 2012;12:6. PMID: 22448610. https://doi.org/10.1186/1472-6874-12-6
Rogers TS, Bieck AM. Management of Uterine Fibroids. Am Fam Physician. 2019;99(5):330-333. PMID: 30811168.
Vines AI, Ta M, Esserman DA. The association between self-reported major life events and the presence of uterine fibroids. Womens Health Issues. 2010;20(4):294-298. PMID: 20627775. https://doi.org/10.1016%2Fj.whi.2010.03.009
Coyne KS, Margolis MK, Bradley LD, Guido R, Maxwell GL, Spies JB. Further validation of the uterine fibroid symptom and quality-of-life questionnaire. Value Health. 2012;15(1):135-142. PMID: 22264981. https://doi.org/10.1016/j.jval.2011.07.007
Published
How to Cite
Issue
Section
Copyright (c) 2022 International Journal of Clinical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.